K

Klaria Pharma Holding AB (publ)
STO:KLAR

Watchlist Manager
Klaria Pharma Holding AB (publ)
STO:KLAR
Watchlist
Price: 0.914 SEK -7.68% Market Closed
Market Cap: 224.8m SEK

Intrinsic Value

The intrinsic value of one KLAR stock under the Base Case scenario is 1.068 SEK. Compared to the current market price of 0.914 SEK, Klaria Pharma Holding AB (publ) is Undervalued by 14%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

KLAR Intrinsic Value
1.068 SEK
Undervaluation 14%
Intrinsic Value
Price
K
Worst Case
Base Case
Best Case

Valuation History
Klaria Pharma Holding AB (publ)

What is Valuation History?
Ask AI Assistant
What other research platforms think about KLAR?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is KLAR valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Klaria Pharma Holding AB (publ).

Explain Valuation
Compare KLAR to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about KLAR?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Klaria Pharma Holding AB (publ)

Current Assets 5m
Cash & Short-Term Investments 2.5m
Receivables 2.5m
Non-Current Assets 42.4m
PP&E 811k
Intangibles 41.6m
Current Liabilities 42.3m
Other Current Liabilities 42.3m
Non-Current Liabilities 619k
Long-Term Debt 617k
Other Non-Current Liabilities 2k
Efficiency

Free Cash Flow Analysis
Klaria Pharma Holding AB (publ)

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Klaria Pharma Holding AB (publ)

Revenue
11.2m SEK
Operating Expenses
-53m SEK
Operating Income
-41.8m SEK
Other Expenses
-4.2m SEK
Net Income
-46m SEK
Fundamental Scores

KLAR Profitability Score
Profitability Due Diligence

Klaria Pharma Holding AB (publ)'s profitability score is 14/100. The higher the profitability score, the more profitable the company is.

Operating Margin is Increasing
Net Margin is Increasing
Low 3Y Average Gross Margin
Low Gross Margin
14/100
Profitability
Score

Klaria Pharma Holding AB (publ)'s profitability score is 14/100. The higher the profitability score, the more profitable the company is.

KLAR Solvency Score
Solvency Due Diligence

Klaria Pharma Holding AB (publ)'s solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
35/100
Solvency
Score

Klaria Pharma Holding AB (publ)'s solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KLAR Price Targets Summary
Klaria Pharma Holding AB (publ)

Wall Street analysts forecast KLAR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KLAR is 0.994 SEK with a low forecast of 0.985 SEK and a high forecast of 1.024 SEK.

Lowest
Price Target
0.985 SEK
8% Upside
Average
Price Target
0.994 SEK
9% Upside
Highest
Price Target
1.024 SEK
12% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Klaria Pharma Holding AB (publ)
does not pay dividends
Shareholder Yield

Current shareholder yield for KLAR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one KLAR stock?

The intrinsic value of one KLAR stock under the Base Case scenario is 1.068 SEK.

Is KLAR stock undervalued or overvalued?

Compared to the current market price of 0.914 SEK, Klaria Pharma Holding AB (publ) is Undervalued by 14%.

Back to Top